279 related articles for article (PubMed ID: 10640744)
1. T cells can induce somatic mutation in B cell receptor-engaged BL2 Burkitt's lymphoma cells independently of CD40-CD40 ligand interactions.
Denépoux S; Fournier N; Péronne C; Banchereau J; Lebecque S
J Immunol; 2000 Feb; 164(3):1306-13. PubMed ID: 10640744
[TBL] [Abstract][Full Text] [Related]
2. B cell receptor engagement and T cell contact induce Bcl-6 somatic hypermutation in human B cells: identity with Ig hypermutation.
Zan H; Li Z; Yamaji K; Dramitinos P; Cerutti A; Casali P
J Immunol; 2000 Jul; 165(2):830-9. PubMed ID: 10878357
[TBL] [Abstract][Full Text] [Related]
3. Induction of Ig somatic hypermutation and class switching in a human monoclonal IgM+ IgD+ B cell line in vitro: definition of the requirements and modalities of hypermutation.
Zan H; Cerutti A; Dramitinos P; Schaffer A; Li Z; Casali P
J Immunol; 1999 Mar; 162(6):3437-47. PubMed ID: 10092799
[TBL] [Abstract][Full Text] [Related]
4. Induction of somatic mutation in a human B cell line in vitro.
Denépoux S; Razanajaona D; Blanchard D; Meffre G; Capra JD; Banchereau J; Lebecque S
Immunity; 1997 Jan; 6(1):35-46. PubMed ID: 9052835
[TBL] [Abstract][Full Text] [Related]
5. CD40 ligation induces Apo-1/Fas expression on human B lymphocytes and facilitates apoptosis through the Apo-1/Fas pathway.
Schattner EJ; Elkon KB; Yoo DH; Tumang J; Krammer PH; Crow MK; Friedman SM
J Exp Med; 1995 Nov; 182(5):1557-65. PubMed ID: 7595225
[TBL] [Abstract][Full Text] [Related]
6. Somatic mutations in human Ig variable genes correlate with a partially functional CD40-ligand in the X-linked hyper-IgM syndrome.
Razanajaona D; van Kooten C; Lebecque S; Bridon JM; Ho S; Smith S; Callard R; Banchereau J; Brière F
J Immunol; 1996 Aug; 157(4):1492-8. PubMed ID: 8759730
[TBL] [Abstract][Full Text] [Related]
7. Somatic mutation of immunoglobulin V genes in vitro.
Källberg E; Jainandunsing S; Gray D; Leanderson T
Science; 1996 Mar; 271(5253):1285-9. PubMed ID: 8638111
[TBL] [Abstract][Full Text] [Related]
8. Analysis of VH genes used by neoplastic B cells in endemic Burkitt's lymphoma shows somatic hypermutation and intraclonal heterogeneity.
Chapman CJ; Mockridge CI; Rowe M; Rickinson AB; Stevenson FK
Blood; 1995 Apr; 85(8):2176-81. PubMed ID: 7718888
[TBL] [Abstract][Full Text] [Related]
9. In vitro triggering of somatic mutation in human naive B cells.
Razanajaona D; Denépoux S; Blanchard D; de Bouteiller O; Liu YJ; Banchereau J; Lebecque S
J Immunol; 1997 Oct; 159(7):3347-53. PubMed ID: 9317133
[TBL] [Abstract][Full Text] [Related]
10. CD40 ligand exerts differential effects on the expression of I gamma transcripts in subclones of an IgM+ human B cell lymphoma line.
Ford GS; Yin CH; Barnhart B; Sztam K; Covey LR
J Immunol; 1998 Jan; 160(2):595-605. PubMed ID: 9551893
[TBL] [Abstract][Full Text] [Related]
11. Engagement of CD40 antigen with soluble CD40 ligand up-regulates peptide transporter expression and restores endogenous processing function in Burkitt's lymphoma cells.
Khanna R; Cooper L; Kienzle N; Moss DJ; Burrows SR; Khanna KK
J Immunol; 1997 Dec; 159(12):5782-5. PubMed ID: 9550373
[TBL] [Abstract][Full Text] [Related]
12. CD40 engagement triggers switching to IgA1 and IgA2 in human B cells through induction of endogenous TGF-beta: evidence for TGF-beta but not IL-10-dependent direct S mu-->S alpha and sequential S mu-->S gamma, S gamma-->S alpha DNA recombination.
Zan H; Cerutti A; Dramitinos P; Schaffer A; Casali P
J Immunol; 1998 Nov; 161(10):5217-25. PubMed ID: 9820493
[TBL] [Abstract][Full Text] [Related]
13. Regulation of cytoplasmic, surface and soluble forms of CD40 ligand in mouse B cells.
Wykes M; Poudrier J; Lindstedt R; Gray D
Eur J Immunol; 1998 Feb; 28(2):548-59. PubMed ID: 9521065
[TBL] [Abstract][Full Text] [Related]
14. CD40 cross-linking inhibits specific antibody production by human B cells.
Callard RE; Herbert J; Smith SH; Armitage RJ; Costelloe KE
Int Immunol; 1995 Nov; 7(11):1809-15. PubMed ID: 8580079
[TBL] [Abstract][Full Text] [Related]
15. A transcriptional defect underlies B lymphocyte dysfunction in a patient diagnosed with non-X-linked hyper-IgM syndrome.
Bhushan A; Barnhart B; Shone S; Song C; Covey LR
J Immunol; 2000 Mar; 164(6):2871-80. PubMed ID: 10706672
[TBL] [Abstract][Full Text] [Related]
16. Regulation of bcl-xL expression and Fas susceptibility in mouse B cells by CD40 ligation, surface IgM crosslinking and IL-4.
Koizumi T; Wang J; Suzuki Y; Masuda K; Watanabe T
Mol Immunol; 1996 Nov; 33(16):1247-53. PubMed ID: 9129161
[TBL] [Abstract][Full Text] [Related]
17. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
[TBL] [Abstract][Full Text] [Related]
18. CD4+ T-cell induction of Fas-mediated apoptosis in Burkitt's lymphoma B cells.
Schattner EJ; Mascarenhas J; Bishop J; Yoo DH; Chadburn A; Crow MK; Friedman SM
Blood; 1996 Aug; 88(4):1375-82. PubMed ID: 8695856
[TBL] [Abstract][Full Text] [Related]
19. Mutations of the CD40 ligand gene and its effect on CD40 ligand expression in patients with X-linked hyper IgM syndrome.
Seyama K; Nonoyama S; Gangsaas I; Hollenbaugh D; Pabst HF; Aruffo A; Ochs HD
Blood; 1998 Oct; 92(7):2421-34. PubMed ID: 9746782
[TBL] [Abstract][Full Text] [Related]
20. A dual role for both CD40-ligand and TNF-alpha in controlling human B cell death.
Lens SM; Tesselaar K; den Drijver BF; van Oers MH; van Lier RA
J Immunol; 1996 Jan; 156(2):507-14. PubMed ID: 8543800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
